2018 IRIS Renal Week Speaker Notes

IRIS Renal Week

Wednesday, March 21, 2018

David Polzin, DVM, PhD, DACVIM (SAIM): History of Veterinary Nephrology

Scott Brown, VMD, PhD, DACVIM (SAIM): Comparative Nephrology

Larry Cowgill, DVM, PhD, DACVIM (SAI): History of Veterinary Extracoporeal Therapies

Jonathan Elliott, MA, VetMB, PhD, CertSAC, DECVPT, MRCVS: History of IRIS

Larry Cowgill, DVM, PhD, DACVIM (SAIM): Clinical Features of Canine Glomerular Disease - Report of the WSAVA Renal Classification Project

Rachel Cianciolo, VMD, PhD, DACVP: Focal Segmental Glomerulosclerosis (FSGS) in Animals

Amanda Coleman, DVM, DACVIM: Overview of Sartins vs ACEi

Shelly Vaden, DVM, PhD, DACVIM (SAIM): Use of Telemisartin for Proteinuria in Dogs with Glomerular Disease

Larry Cowgill, DVM, PhD, DACVIM (SAIM), David Polzin, DVM, PhD, DACVIM (SAIM), JD Foster, VMD, DACVIM (SAIM), Rosanne Jepson, BVSc, MVetMed, PhD, DACVIM (SAIM), DECVIM-CA, PGCertVetEd FHEA MRCVS, RCVS Cathy Langston, DVM, DACVIM, Gilad Segev, DVM, DECVIM, Rachel Cianciolo, VMD, PhD, DACVP, Shelly Vaden, DVM, PhD, DACVIM (SAIM) : Changing Patterns for the Management of Canine Glomerular Disease (panel discussion--no notes)

Jeff Barnes, VP Immutrix Therapeutics, Inc. : Activated Charcoal–An Old Material with New Potential

Phillip P. Chan, MD, PhD, CEO CytoSorbents Corporation: Synthetic Polymer-based Hemoadsorption

Larry Cowgill, DVM, PhD, DACVIM (SAIM) and JD Foster, VMD, DACVIM (SAIM): Efficacy of Therapeutic Plasma Exchange for IMHA—It Should be a First-Line Therapy

Thursday, March 22, 2018

Mark Caulfield, FMedSc., Co-Director, William Harvey Research Institute, Barts &London School of Medicine & Dentistry: The Genomics of Human Hypertension: Time for Translation

Scott Brown, DVM, PhD, DACVIM (SAIM): Update on Hypertension in Animals

Cathy Langston, DVM, DACVIM (SAIM): Prevalence of Hypertension in Differing Patterns of Glomerular Disease

Roseanne Jepson, BVSc, MVetMed, PhD, DACVIM (SAIM), DECVIM-CA, PGCertVetEdFHEA MRCVS, RCVS: Use of Novel Cardiovascular Biomarkers in Feline Hypertension

Jonathan Elliott, MA, VetMB, PhD, CertSAC, DECVPT, MRCVS: Antihypertensive Efficacy of Telmisartin vs. Amlodipine

Friday, March 23, 2018

Chirag Parikh, MD, Professor of Nephrology: Urine Sediment Evaluation & Urinary Sediment Score

Gilad Segev, DVM, DECVIM: Novel Urinary Biomarkers in AKI

Jane Sykes, BVSc (Hons), PhD, DACVIM (SAIM): Should Subclinical UTI in the Kidney be Treated?

Shelly Vaden, DVM, PhD, DACVIM(SAIM): Novel Urinary Biomarkers in UTI

David Polzin, DVM, PhD, DACVIM (SAIM): Urinary Biomarkers for the Diagnosis of Progressive CKD

Murthy Yerrimelli, PhD, Vice President-Research & Development,IDEXX: IDEXX SediVue-A New Diagnostics Platform for Urinary Diagnostics (no notes)

Saturday, March 24, 2018

LarryCowgill, DVM, PhD, DACVIM(SAIM): “One Health” Nephrology

JD Foster, VMD, DACVIM (SAIM): Drug Dosing in Kidney Disease

Margo Karriker, PharmD, DVM, PhD, DACVIM (SAIM): Dangerous Drugs in Kidney Disease

Robert T. Nachtrieb: Computerized Simulation of the Nephron (no notes)

Larry Cowgill, DVM, PhD, DACVIM (SAIM): Description of Hemodialysis Academy

Larry Cowgill, DVM, PhD, DACVIM (SAIM) Update of the American College of Veterinary Nephrology/Urology

JD Foster, VMD,DACVIM(SAIM) Update on Veterinary Consensus Guidelines for Extracorporeal Therapies

JD Foster, VMD,DACVIM(SAIM) Update on Veterinary Certification of Extracorporeal Therapies (combined with above presentation)

ABSTRACTS:

Marissa Torre, DVMPerformance of Urine Microscopy in Predicting Urine Culture Results in Dogs and Cats

Ekta Thakkar, B.V.Sc & A.H, M. V. ScTo Study Urea Rebound and Measurement of Dialysis Dose Adequacy

Catherine Lapointe, DVM, MSC, Dipl. AcvimEvaluation of SDMA in Dogs – Does Blood Pressure Influences SDMA Levels?

Sabrina Clark, DVM, DACVP PhD CandidateAbnormal Expression of miRNAs in Dogs with X-Linked Hereditary Nephropathy